Philip Astley-Sparke insider trades

Open-market stock purchases and sales by Philip Astley-Sparke, Unknown at enGene Therapeutics Inc, from SEC Form 4 filings since Jan 27, 2017.

Recent trades

DateStockTradeValue
Jun 16, 2026ENGN enGene Therapeutics IncBought (not open market)—
May 18, 2026REPL Replimune Group, IncSold$89.7K
Apr 1, 2026REPL Replimune Group, IncBought (not open market)—
Apr 1, 2026REPL Replimune Group, IncBought (not open market)—
Feb 18, 2026REPL Replimune Group, IncSold (not open market)—

Companies traded

  • ENGN enGene Therapeutics Inc: other filings, last Jun 16, 2026
  • REPL Replimune Group, Inc: 25 sales, last May 18, 2026
  • QURE uniQure NV: 14 sales, last Mar 2, 2021

Get free alerts when Philip Astley-Sparke files a new trade →